Substance
ID:1240
Names and Identifiers
IUPAC name
6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1,2,3-benzotriazole-5-carboxamide
Brand Name
LiticumLimican
Synonyms
Alizapridum [inn-latin]Alizaprida [inn-spanish]Alizapride
IUPAC Traditional name
alizapride
Properties
Physical Property
Hydrophobicity(logP)
1.79 [MANNHOLD,R ET AL. (1990)]
Molecule Details
Drug Groups
approved
Description
Alizapride is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.
Indication
Alizapride is used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.
Pharmacology
Alizapride is a dopamine antagonist.
Half Life
3 hours
Elimination
renal
References
•
Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M: Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Cancer Chemother Pharmacol. 1988;22(4):316-20.
[Pubmed]
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
• Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M: Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Cancer Chemother Pharmacol. 1988;22(4):316-20. Pubmed